Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesAnti–vascular endothelial growth factor activity in the bevacizumab and triamcinolone acetonide combination for intravitreal use
European Journal of Ophthalmology, 08/24/09
Giammaria D et al. – After storage at 4°C for 48 hours and 1 week, the combined preparations showed a larger reduction in bevacizumab concentration than the control preparations. No significant change was observed with the length of storage. The preparations obtained mixing 4 mg/0.05 mL of TA and 1.25 mg/0.05 mL of bevacizumab maintained the highest anti–VEGF activity over time.
Related Articles
Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors
Journal of Clinical Oncology, 11/19/09
Relevance Score: 92%
Effect of bevacizumab in older patients with metastatic colorectal cancer: Pooled analysis of four randomized studies
Journal of Cancer Research & Clinical Oncology, 11/17/09
Relevance Score: 91%
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09
Relevance Score: 91%
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer
Journal of Clinical Oncology, 10/22/09
Relevance Score: 89%
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501
Journal of Clinical Oncology, 10/15/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration
Journal of Clinical Ultrasound, 12/03/09
N-Acetylcarnosine Lubricant Eyedrops Possess All-In-One Universal Antioxidant Protective Effects of L-Carnosine in Aqueous and Lipid Membrane Environments, Aldehyde Scavenging, and Transglycation Activities Inherent to Cataracts: A Clinical Study of the New Vision-Saving Drug N-Acetylcarnosine Eyedrop Therapy in a Database Population of Over 50,500 Patients
American Journal of Therapeutics, 12/02/09
Photodynamic Therapy With and Without Adjunctive Intravitreal Triamcinolone Acetonide
Ophthalmic Surgery, Lasers and Imaging, 12/01/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Downregulation of Serum IGF-1 for Treatment of Early Worsening of Diabetic Retinopathy: A Long-Term Follow-Up of Two Cases
Ophthalmologica, 12/04/09
Pegylated-Interferon-Associated Retinopathy in Chronic Hepatitis Patients
Ophthalmologica, 12/04/09
Retinal astrocytes respond to IL-17 differently than retinal pigment epithelial cells
Journal of Leukocyte Biology, 12/04/09
Article Search
Sponsor